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ABSTRACT
Objective. The aims of our study were 
to investigate the prevalence of ultra-
sound (US) abnormalities in the foot of 
patients with osteoarthritis (OA) and to 
compare them with clinical findings.
Methods. Consecutive patients with 
foot OA were investigated by clinical 
and US examinations. Bilateral US 
of the midfoot and forefoot joints was 
performed by using a Logiq9 machine, 
equipped with a multi-frequency linear 
probe, operating at 14 MHz; in addi-
tion, power Doppler was applied (fre-
quency 7.5 MHz; gain 50%; PRF 750 
Hz). Clinical evaluation included the 
registration of demographic data, dis-
ease duration, current treatment under-
gone, joint swelling and tenderness. US 
study included the assessment of both 
inflammatory (joint effusion, synovial 
hypertrophy, local pathologic vascu-
larisation at PD, big-toe bursitis) and 
structural (osteophytes, MTP joints 
subluxation) abnormalities.
Results. One hundred patients were 
studied. At midfoot level, clinical ex-
amination demonstrated signs sugges-
tive for joint inflammation (tenderness 
and/or swelling) in at least one joint in 
43/200 feet (21.5%) of 23 patients; US 
showed inflammatory abnormalities in 
87/200 feet (43.5%) of 63 patients and 
structural lesions in 100/200 feet (50%) 
of 70 patients. At forefoot level, clinical 
examination found inflammatory signs 
in at least one joint in 128 feet (64%) 
of 64 patients; US showed inflamma-
tory abnormalities in at least one joint 
in 176 feet (88%) of 88 patients and 
structural lesions in 189 feet (86%) of 
86 patients. 
Conclusions. US is a useful imaging 
tool for analysing both inflammatory 
and structural damage lesions at foot 
joints level in OA. In addition, it dem-
onstrated to be more sensitive than 
clinical examination in the detection of 
inflammatory abnormalities.
Introduction
Osteoarthritis (OA) is an extremely 
common rheumatic disease that affects 
most peripheral joints. Both structural 
damage lesions and inflammatory ab-
normalities are present during the dis-
ease course, with evidence of a wide 
set of changes that involve all joint 
structures. The common active disease 
process, indeed, affects all tissues of the 
joint and determines dysregulation of 
normal tissue turnover and repair, lead-
ing to a failure of the whole joint (1, 2). 
The most common pathologic aspects 
are characterised by hyaline cartilage 
damage, bone and capsule hypertrophy 
and episodic synovitis (3). The foot is 
involved with a variable frequency ac-
cording to the joint sites, hindfoot OA 
being uncommon, but forefoot OA is 
a frequent joint disease, particularly at 
the level of the first metatarsophalan-
geal joint, that represents the prime 
site of OA changes. Hallux valgus and 
hallux rigidus are extremely common 
problems, especially in women, and 
seem to be dependent on metatarsal de-
formities due to the use of inappropriate 
modern footwear (3). This results in the 
appearance of both radiographic mani-
festations and symptoms that may lead 
to relevant discomfort associated with 
pain, difficulty in walking and local de-
formations. Radiography represents the 
gold standard imaging modality for as-
sessing OA joints and it is particularly 
valuable in detecting some structural 
osteoarthritis lesions. However, it is not 
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able to show soft tissue changes and 
demonstrate the presence of inflamma-
tory abnormalities occurring in OA (1). 
It has been demonstrated that muscu-
loskeletal ultrasound (US) is a valuable 
tool for imaging most musculoskeletal 
changes in rheumatic diseases (4). Over 
the last few years, its role has been un-
derlined also in OA, due to its ability in 
showing early and late findings related 
both to inflammation and structural 
damage (1, 5-8). The fact that it is a 
safe tool has contributed to its increas-
ingly widespread use, and it is now 
considered as a bedside procedure in 
rheumatology (9). Notwithstanding its 
increasing applications in the assess-
ment of various abnormalities occur-
ring in OA and its increased sensitivity 
with respect to clinical examination in 
detecting joint involvement in rheu-
matic diseases, its role in assessing foot 
lesions in OA is still to be defined.
The aims of our study were to investi-
gate the prevalence of US abnormalities 
in the feet of patients with OA and to 
compare them with clinical findings.
Patients and methods
Consecutive patients with clinical and 
radiographic signs of OA involving 
the feet were included in the present 
study, independently of disease dura-
tion and severity of clinical signs of 
foot involvement. All patients were in-
vestigated both by clinical assessment 
and US examination in both feet. The 
study was conducted in 4 Italian units 
of rheumatology (Sapienza Università 
di Roma, Università Politecnica delle 
Marche, Università di Pisa and Univer-
sità di Pavia). 
Prior to US evaluation, clinical assess-
ment was performed by an expert rheu-
matologist who registered the demo-
graphic data, disease duration and cur-
rent treatment undergone. In addition, 
the presence/absence of joint swelling 
and tenderness (by palpation and ac-
tive/passive mobilisation of the foot) 
were recorded, both at midfoot and 
forefoot level. The list of the assessed 
joints is reported in Table I. 
The presence of any other rheumatic 
disease and the history of either severe 
trauma or surgery of the foot were the 
criteria for exclusion from the study. 
The study was conducted according to 
the Declaration of Helsinki and local 
regulations, and informed consent was 
obtained from all patients.
Ultrasound
Prior to patients’ enrolment, the US ex-
amination methodology was clarified 
among sonographers and a consensus 
was obtained on scanning protocol 
and image interpretation. In the 4 units 
participating in the study, US examina-
tion was separately and independently 
performed by a single ultrasonographer 
who was a rheumatologist experienced 
in musculoskeletal US and was blinded 
to the clinical and laboratory findings. 
Bilateral US of the midfoot and fore-
foot joints was performed the same 
day of the clinical evaluation by using 
a Logiq9 machine (General Electrics 
Medical Systems, Milwaukee, WI), 
equipped with a multi-frequency linear 
probe, operating at 14 MHz. In addi-
tion, power Doppler (PD) was applied 
(frequency 7.5 MHz; gain 50%; PRF 
750 Hz). The same equipment set-
tings, which had been previously stand-
ardised, were used in all cases. At the 
beginning of each scanning session at 
different joint sites, the focus was posi-
tioned at the level of the region of inter-
est. Colour gain was adjusted just below 
the degree that caused the appearance 
of noise artefacts (10). The colour box 
was positioned at the level of the joint 
area to be examined, enlarging the box 
to the upper part of the image. Table I 
reports the list of the joints examined, 
both at midfoot and forefoot levels.
Patients were asked to adopt a supine 
position with the foot resting on the 
examination table and the knee flexed 
at 60°. After the gel was applied to the 
skin to provide an appropriate acoustic 
interface, US examinations were carried 
out, paying attention so as not to apply 
probe pressure on the anatomical struc-
tures under examination. According to 
the EULAR guidelines for musculoskel-
etal US in rheumatology, in all cases, 
longitudinal and transverse multiplanar 
scans were performed at the level of the 
dorsal, lateral and medial aspects of the 
foot, depending on the joint subjected to 
examination (11) (Table I). During the 
same scanning session, US was initially 
performed in B-mode modality with the 
aim of detecting morphological chang-
es and immediately afterwards using 
PD technique searching for local abnor-
mal vascularisation. According to com-
monly used international definitions of 
pathological findings and including the 
assessment of both inflammatory and 
structural abnormalities, the following 
changes were registered: joint effusion, 
synovial hypertrophy, local pathologic 
Table I. Joints evaluated by clinical assessment and ultrasonographic examination.
Midfoot Sub-talar (talo-calcanear) joint
 Talo-navicular joint
 Navicular-cuneiform (medial, intermediate, lateral)
 Calcaneo-cuboidal joint
 Cubo-navicular joint
 Inter-cuneiform joint (medial, lateral)
 Cuboido-cuneiform joint
 Medial cuneiform-metatarsal joint (I-V)
Forefoot Metatarsophalangeal joints (I-V)
 I Interphalangeal joint
 Proximal-interphalangeal joints (II-V)
 Distal-interphalangeal joints (II-V)
Table II. Patients clinical and demographic characteristics and treatment assumed.
Number of patients    n=100
Gender (female/male)    57/43
Age in years (mean ± SD)   65.4 ± 10.8
Disease duration in months (mean ± SD)  13.7 ± 11.05
Therapy (n /%)
Analgesic drugs    55 (55%)
NSAIDs     37 (37%)
Chondroprotective drugs   10 (10%)
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vascularisation at PD, big-toe bursi-
tis, osteophytes, metatarsophalangeal 
(MTP) joints subluxation (12-14). All 
lesions were registered according to a 
dichotomous (presence/absence) score. 
Single joints were considered involved 
when at least one abnormality was de-
tected by US. In addition, the most fre-
quently involved joint both at midfoot 
and forefoot level was registered. 
Statistical analysis
The statistical calculations were made 
using Statistical Package for Social 
Sciences 13.0 (SPSS, Chicago, IL, 
USA) and GraphPad 5.0 (La Jolla, CA, 
USA). Normally distributed variables 
were summarised using the mean±SD, 
and non-normally distributed variables 
by the median and range. Wilcoxon’s 
matched pairs test and paired t-test 
were performed. Univariate compari-
sons between nominal variables were 
calculated using chi-square (χ2) test or 
Fisher’s exact test, where appropriate. 
Two-tailed p-values were reported; p-
values less than or equal to 0.05 were 
considered significant.
Results 
Patients’ clinical and demographic 
characteristics, as well as the treatment 
undergone at the time of enrolment, are 
reported in Table II. 
A total of 200 feet (100 patients) were 
examined both by clinical examination 
and US assessment. 
Results of US-detected abnormalities 
are reported separately for midfoot 
and forefoot in Tables III and IV, re-
spectively. Relationships between US 
and clinical findings indicative of foot 
joints inflammation are reported in ta-
bles 5 and 6 for midfoot and forefoot 
assessment, respectively.
At midfoot level, clinical examina-
tion demonstrated signs suggestive of 
joint inflammation (tenderness / swell-
ing) in at least one joint in 43/200 feet 
(21.5%) of 23 patients. US showed 
inflammatory abnormalities in 87/200 
feet (43.5%) of 63 patients, and dem-
onstrated that the most frequently in-
volved articular sites were the subtalar, 
talonavicular and navicular-cuneiform 
medial and intermediate joints, where 
the most common pathologic US find-
ing was joint effusion, that was present 
globally in 55.3% of the joints exam-
ined; synovial hypertrophy was found 
in 9% of the midfoot joints and positive 
PD signal in 0.6%. The analysis of the 
single abnormalities at different joint 
sites demonstrated that effusion was 
present from 96.6% to 100% of the 
involved joints; synovial hypertrophy 
was detected from 9.3% to 27.3% of 
the involved articular sites; finally, PD-
detected pathological vascularisation 
was present only in 9% of the involved 
joints and exclusively at talonavicular 
joint level Table III). US-detected struc-
tural lesions were shown in 100/200 
feet (50%) of 70 patients with a global 
evidence of osteophytes in 34% of the 
examined joints. Particularly, 100% of 
the involved joints presented the evi-
dence of osteophytes at subtalar joint 
level; the other midfoot joints showed 
osteophytes from 48.8% to 81.8% of 
the involved cases (Table III). 
At forefoot level, clinical examination 
found inflammatory abnormalities in at 
least one joint in 128 feet (64%) of 64 
patients; in all cases MTP joints were 
involved. Only 4 patients showed in-
volvement of proximal interphalangeal 
(PIP) joints and 3 of DIP distal inter-
phalangeal (DIP) joints. US showed 
inflammatory abnormalities in at least 
one joint in 176 feet (88%) of 88 pa-
tients. At MTP joints level, globally 
joint effusion (Fig. 1a) was the most 
frequent US finding (90.3% of the ex-
amined joints), followed by synovial 
hypertrophy (Fig. 1a-c) (50%), positive 
PD signal (Fig. 1c) (6.8%) and hallux 
bursitis (3.9%). The analysis of the dif-
ferent abnormalities showed that effu-
sion was found from 43.7% to 100% of 
the involved joints; synovial hypertro-
phy was present from 3.8% to 98.1% 
Table III. US-detected inflammatory and structural abnormalities at midfoot level.
 
 Patients Feet Joint * Synovial PD signal*  Osteophytes*
   effusion hypertrophy* 
Subtalar joint (n / %) 16 / 16 16 / 8.8 16 / 100 2 / 12.5 0 16 /100
Talonavicular joint (n / %) 16 / 16 22 / 11 22 / 100 6 / 27.3 2 / 9 18 / 81.8
Navicular-cuneiform  joint (n / %) 
- Medial 27 / 27 30 / 15 29 / 96.6 3 / 10 0 15 / 50
- Intermediate 29 / 29 43 / 21.5 43 / 100 4 / 9.3 0 21 / 48.8
*the percentage of abnormalities is calculated on the basis of the number of feet involved.
Table IV. US-detected inflammatory and structural abnormalities at forefoot level. 
 Patients Feet Joint * Synovial PD signal* Bursitis* Osteophytes* Subluxation*
   effusion hypertrophy*  (big toe) 
I MTP (n / %) 78 / 78 167 / 39 73 / 43.7 44 / 26.3 2 / 1.2 11 / 6.6 167 / 100 27 / 16.1
II MTP (n / %) 35 / 35 53 / 26.5 44 / 83 52 / 98.1 15 / 28.3 – 35 / 66 0
III MTP (n / %) 48 / 48 60 / 30 60 / 100 37 / 61.6 2 / 3.3 – 28 / 46.6 0
IV MTP (n / %) 13 / 13 17 / 8.5 17 / 100 6 / 35.3 0 – 10 / 58.8 0
V MTP (n / %) 22 / 22 26 / 13 25 / 96.1 1 / 3.8 0 – 24 / 92.3 2 / 7.7
*the percentage of abnormalities is calculated on the basis of the number of feet involved.
760
IMAGING Sonographic assessment of the foot in patients with OA / A. Iagnocco et al.
of involved articular sites; PD signal 
was positive only the I, II and III MTP 
joints (1.2%–28.3%); and hallux bursi-
tis was preset in 6.6% of the involved 
joints (Table IV). At PIP joints level, 
US inflammatory signs were identi-
fied in 15 patients (15%, 20 feet) and 
were only represented by the finding of 
joint effusion. One patient showed the 
concomitant involvement of right II, III 
and IV PIP. Only 2 patients showed the 
involvement of DIP joints (II DIP bilat-
erally and right III DIP, respectively). 
US showed the presence of structural 
lesions in 189 feet (86%) of 86 patients. 
In particular, 100% of the involved I 
MTP joints were the site of osteophytes 
and 16.1% of subluxation; osteophytes 
were detected from 46.6% to 92.3% 
of the other involved MTP joints; sub-
luxation, that was found exclusively at 
the level of the V MTP joints, was rare 
(7.7% of involved joints) (Table IV). 
In addition, the analysis of the relation-
ships between US and clinical findings 
indicative of foot joints inflammation 
demonstrated that 49 patients nega-
tive for clinical midfoot involvement 
showed US abnormalities; on the con-
trary, only in 5 patients without any 
US-detected lesions, clinical exami-
nation demonstrated signs suggestive 
of joint inflammation (Table V). At 
forefoot level, correlations between 
US abnormalities and clinically-de-
tected findings showed that 56 patients 
negative to clinical examination were 
positive to US findings; only 8 patients 
without any sonographic evidence of 
abnormalities were positive to clinical 
assessment (Table VI).
Discussion 
As far as we know, this is the first ul-
trasonographic study focused on the 
evaluation of the foot in patients with 
OA. US demonstrated a wide range of 
abnormalities that were related both to 
joint inflammation and structural dam-
age lesions. Forefoot disease, in par-
ticular, is a very frequent cause of com-
plaint for a huge number of OA patients 
who usually refer persistent symptoms 
at MTP joints that may lead to impair-
ment and possible disability. This fea-
ture of disease often requires particular 
attention by the clinicians who may, 
Fig. 1. Ultrasound of the foot in osteoarthritis. a. longitudinal dorsal scan of the I MTP joint: evidence 
of large osteophytes (è). b. longitudinal dorsal scan of the II MTP joint: presence of synovial hyper-
trophy, joint effusion and small osteophytes (è). c. Power Doppler US of the I MTP joint; longitudinal 
dorsal scan: moderate pathological hypervascularisation of the synovial membrane, indicative of active 
synovitis; large osteophytes (è) are also present. m: metatarsal bone. p: proximal phalanx.
Table VI. Relationships between US and clinical findings indicative of foot joints inflam-
mation at forefoot level.
 Clinical findings
  Presence (n. feet) Absence (n. feet) Total
Forefoot US findings   
 Presence (n. feet) 120 56  176
 Absence (n. feet) 8 16 24
 Total 128 72 200
Table V. Relationships between US and clinical findings indicative of foot joints inflam-
mation at midfoot level.
 
 Clinical findings
  Presence (n. feet) Absence (n. feet) Total
Midfoot US findings   
 Presence (n. feet) 38 49 87
 Absence (n. feet) 5 108 113
 Total 43 157 200
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therefore, consider the role of US in the 
management of OA patients. 
The present study, for the first time 
showed that midfoot is a possible site 
for pathology in OA, demonstrating 
that 43.5% of the joints presented with 
signs of inflammatory abnormalities 
that were mainly represented by joint 
effusion. Interestingly, pathologic find-
ings were detected also in joints without 
any clinical evidence of inflammatory 
involvement. This particular feature 
confirms the results obtained by pre-
vious studies that have underlined the 
higher sensitivity of US with respect 
to clinical examination in the detection 
of joint inflammation, with the capabil-
ity of US to detect subclinical synovi-
tis (15-21). In addition, US was able 
to demonstrate the presence of osteo-
phytes in 34% of the joints at midfoot 
level. Again, this finding is of particular 
interest, being the midfoot considered a 
relatively uncommon site for OA. 
At forefoot level, US demonstrated 
a very high incidence of inflamma-
tory findings that, as expected, were 
mainly present at MTP joints. Unlike 
the midfoot joints, MTP involvement 
was represented both by joint effusion 
and synovial hypertrophy, with possi-
ble presence also of local pathological 
vascularisation at PD. The finding of 
synovitis at the MTP joint level ap-
pears particularly valuable, since MTP 
joints is a target site for OA. Thus, US 
can be considered a useful tool for in-
dicating the presence of inflammatory 
abnormalities since early disease. In-
deed, the increased value of US seems 
to be related, again, to its higher sensi-
tivity with respect to clinical examina-
tion in detecting subclinical inflamma-
tory joint findings (15, 16). Failure to 
detect synovitis could delay treatment 
and lead to joint impairment. Thus, cli-
nicians may be cautious in determining 
the presence or absence of synovitis on 
the basis of clinical examination alone; 
this aspect reflects the need for US to 
help increase their diagnostic confi-
dence (17). In addition, our study dem-
onstrated an extensive involvement of 
the forefoot, with evidence of diffuse 
structural lesions that were mainly 
characterised by frequent detection of 
osteophytes. 
The limitation of our study is represent-
ed by the lack of data on cartilage dam-
age assessment. Indeed, a noteworthy 
limitation of US is represented by the 
incomplete evaluation of hyaline carti-
lage which is the target tissue in OA. 
Particularly, the sonographic evalua-
tion of that anatomic structure is based 
on the use of appropriate acoustic win-
dows which, at foot level, do not permit 
an extensive assessment of it. Cartilage 
evaluation was, therefore, excluded by 
our analysis that was mainly focused 
on the detection of the other main path-
ological features of disease.
In conclusion, the present study showed 
that US is a useful imaging tool for ana-
lysing both inflammatory and structural 
damage lesions at the foot joint level 
in OA. The foot is a complex anatomic 
area with a huge number of joints that 
are difficult to assess by physical ex-
amination. On the contrary, US is able 
to distinguish the various possible ar-
ticular sites involved and can detect a 
wide set of lesions (22, 23). In addition, 
it demonstrated that it was more sensi-
tive than clinical examination in the de-
tection of inflammatory abnormalities, 
therefore supporting the emerging evi-
dence for its widespread application in 
OA. Overall, the use of US in foot OA 
patients provides additional informa-
tion to be integrated with clinical histo-
ry and physical examination and which 
help in the management of the disease, 
indicating the presence of inflammatory 
findings as well as of structural dam-
age lesions since early disease. Due to 
its non-invasiveness and limited costs 
and based on the high prevalence of 
OA, US can be routinely used to dis-
criminate between different subsets of 
disease, helping in the characterisation 
of patients with a more aggressive pa-
thology as well as in finding the sub-
jects with a more severe prognosis. The 
widespread use of US in the assessment 
and management of patients with foot 
OA is therefore recommended. 
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